Invention Grant
- Patent Title: 9-substituted minocycline compounds
- Patent Title (中): 9-取代的米诺环素化合物
-
Application No.: US12351405Application Date: 2009-01-09
-
Publication No.: US08258120B2Publication Date: 2012-09-04
- Inventor: Mark L. Nelson , Mohamed Y. Ismail , Laura Honeyman
- Applicant: Mark L. Nelson , Mohamed Y. Ismail , Laura Honeyman
- Applicant Address: US MA Boston US MA Medford
- Assignee: Paratek Pharmaceuticals, Inc.,Trustees of Tufts College
- Current Assignee: Paratek Pharmaceuticals, Inc.,Trustees of Tufts College
- Current Assignee Address: US MA Boston US MA Medford
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Agent Heidi A. Erlacher; Chen Chen
- Main IPC: A61K31/65
- IPC: A61K31/65 ; C07C237/26
Abstract:
The present invention pertains, at least in part, to novel 9-substituted minocycline compounds. These minocycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for minocycline and tetracycline compounds in general, such as blocking tetracycline efflux and modulation of gene expression.
Public/Granted literature
- US20090325908A1 9-SUBSTITUTED MINOCYCLINE COMPOUNDS Public/Granted day:2009-12-31
Information query
